nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Methotrexate—multiple sclerosis	0.0927	0.151	CbGbCtD
Gemfibrozil—CYP3A4—Fingolimod—multiple sclerosis	0.0812	0.133	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—multiple sclerosis	0.0656	0.107	CbGbCtD
Gemfibrozil—CYP3A4—Methylprednisolone—multiple sclerosis	0.0523	0.0854	CbGbCtD
Gemfibrozil—CYP2C8—Dexamethasone—multiple sclerosis	0.0488	0.0797	CbGbCtD
Gemfibrozil—CYP2C19—Dexamethasone—multiple sclerosis	0.0409	0.0668	CbGbCtD
Gemfibrozil—CYP3A4—Triamcinolone—multiple sclerosis	0.0397	0.0647	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0382	0.0623	CbGbCtD
Gemfibrozil—CYP2C9—Dexamethasone—multiple sclerosis	0.034	0.0556	CbGbCtD
Gemfibrozil—CYP3A4—Betamethasone—multiple sclerosis	0.034	0.0556	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—multiple sclerosis	0.0336	0.0548	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—multiple sclerosis	0.0317	0.0518	CbGbCtD
Gemfibrozil—CYP3A4—Dexamethasone—multiple sclerosis	0.0198	0.0323	CbGbCtD
Gemfibrozil—PPARA—Nuclear Receptors—PGR—multiple sclerosis	0.00152	0.0222	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00144	0.021	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.0012	0.0175	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00116	0.0169	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00114	0.0166	CbGpPWpGaD
Gemfibrozil—PPARA—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00107	0.0156	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—VDR—multiple sclerosis	0.00106	0.0155	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transport of organic anions—ALB—multiple sclerosis	0.00101	0.0148	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000937	0.0136	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000937	0.0136	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00084	0.0122	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000801	0.0117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000801	0.0117	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000751	0.0109	CbGpPWpGaD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000731	0.0106	CbGpPWpGaD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000731	0.0106	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CD24—multiple sclerosis	0.000726	0.0106	CbGpPWpGaD
Gemfibrozil—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000721	0.0105	CbGpPWpGaD
Gemfibrozil—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000721	0.0105	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000688	0.01	CbGpPWpGaD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000652	0.0095	CbGpPWpGaD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000652	0.0095	CbGpPWpGaD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000644	0.00938	CbGpPWpGaD
Gemfibrozil—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000644	0.00938	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000618	0.009	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000618	0.009	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000595	0.00866	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000595	0.00866	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000592	0.00863	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000592	0.00863	CbGpPWpGaD
Gemfibrozil—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000587	0.00855	CbGpPWpGaD
Gemfibrozil—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000587	0.00855	CbGpPWpGaD
Gemfibrozil—PPARA—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000572	0.00833	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000571	0.00831	CbGpPWpGaD
Gemfibrozil—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000547	0.00797	CbGpPWpGaD
Gemfibrozil—Angioedema—Prednisolone—multiple sclerosis	0.000542	0.0017	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00054	0.00169	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—multiple sclerosis	0.00054	0.00169	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000537	0.00168	CcSEcCtD
Gemfibrozil—Dysgeusia—Triamcinolone—multiple sclerosis	0.000534	0.00167	CcSEcCtD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000533	0.00776	CbGpPWpGaD
Gemfibrozil—Nausea—Cladribine—multiple sclerosis	0.000533	0.00167	CcSEcCtD
Gemfibrozil—Vertigo—Prednisolone—multiple sclerosis	0.000533	0.00167	CcSEcCtD
Gemfibrozil—Syncope—Prednisolone—multiple sclerosis	0.000532	0.00167	CcSEcCtD
Gemfibrozil—Eye disorder—Betamethasone—multiple sclerosis	0.000531	0.00166	CcSEcCtD
Gemfibrozil—Eye disorder—Dexamethasone—multiple sclerosis	0.000531	0.00166	CcSEcCtD
Gemfibrozil—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000529	0.00166	CcSEcCtD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000529	0.0077	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000529	0.0077	CbGpPWpGaD
Gemfibrozil—Somnolence—Mitoxantrone—multiple sclerosis	0.000524	0.00164	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisolone—multiple sclerosis	0.000521	0.00163	CcSEcCtD
Gemfibrozil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000519	0.00163	CcSEcCtD
Gemfibrozil—Convulsion—Prednisolone—multiple sclerosis	0.000514	0.00161	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—multiple sclerosis	0.000511	0.0016	CcSEcCtD
Gemfibrozil—Fatigue—Mitoxantrone—multiple sclerosis	0.000508	0.00159	CcSEcCtD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000508	0.0074	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000508	0.0074	CbGpPWpGaD
Gemfibrozil—Pancreatitis—Methotrexate—multiple sclerosis	0.000506	0.00159	CcSEcCtD
Gemfibrozil—Pain—Mitoxantrone—multiple sclerosis	0.000504	0.00158	CcSEcCtD
Gemfibrozil—Constipation—Mitoxantrone—multiple sclerosis	0.000504	0.00158	CcSEcCtD
Gemfibrozil—Alopecia—Dexamethasone—multiple sclerosis	0.000502	0.00157	CcSEcCtD
Gemfibrozil—Alopecia—Betamethasone—multiple sclerosis	0.000502	0.00157	CcSEcCtD
Gemfibrozil—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000502	0.00731	CbGpPWpGaD
Gemfibrozil—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000502	0.00731	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Azathioprine—multiple sclerosis	0.000499	0.00156	CcSEcCtD
Gemfibrozil—Angioedema—Triamcinolone—multiple sclerosis	0.000498	0.00156	CcSEcCtD
Gemfibrozil—Angioedema—Methylprednisolone—multiple sclerosis	0.000497	0.00156	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—multiple sclerosis	0.000491	0.00154	CcSEcCtD
Gemfibrozil—Vertigo—Triamcinolone—multiple sclerosis	0.00049	0.00154	CcSEcCtD
Gemfibrozil—Syncope—Triamcinolone—multiple sclerosis	0.000489	0.00153	CcSEcCtD
Gemfibrozil—Vertigo—Methylprednisolone—multiple sclerosis	0.000489	0.00153	CcSEcCtD
Gemfibrozil—Syncope—Methylprednisolone—multiple sclerosis	0.000488	0.00153	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Prednisone—multiple sclerosis	0.000486	0.00152	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000486	0.00152	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000484	0.00152	CcSEcCtD
Gemfibrozil—Oedema—Prednisolone—multiple sclerosis	0.000484	0.00152	CcSEcCtD
Gemfibrozil—Dizziness—Azathioprine—multiple sclerosis	0.000482	0.00151	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000482	0.00151	CcSEcCtD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000482	0.00702	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000482	0.00702	CbGpPWpGaD
Gemfibrozil—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000479	0.0015	CcSEcCtD
Gemfibrozil—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000478	0.0015	CcSEcCtD
Gemfibrozil—Shock—Prednisolone—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Gemfibrozil—Cough—Triamcinolone—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Gemfibrozil—Convulsion—Triamcinolone—multiple sclerosis	0.000472	0.00148	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000472	0.00148	CcSEcCtD
Gemfibrozil—Convulsion—Methylprednisolone—multiple sclerosis	0.000471	0.00148	CcSEcCtD
Gemfibrozil—Urticaria—Mitoxantrone—multiple sclerosis	0.000468	0.00147	CcSEcCtD
Gemfibrozil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000466	0.00146	CcSEcCtD
Gemfibrozil—Myalgia—Triamcinolone—multiple sclerosis	0.000464	0.00146	CcSEcCtD
Gemfibrozil—Vomiting—Azathioprine—multiple sclerosis	0.000464	0.00145	CcSEcCtD
Gemfibrozil—Myalgia—Methylprednisolone—multiple sclerosis	0.000463	0.00145	CcSEcCtD
Gemfibrozil—Arthralgia—Methylprednisolone—multiple sclerosis	0.000463	0.00145	CcSEcCtD
Gemfibrozil—Eye disorder—Prednisone—multiple sclerosis	0.000462	0.00145	CcSEcCtD
Gemfibrozil—Rash—Azathioprine—multiple sclerosis	0.00046	0.00144	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00046	0.00144	CcSEcCtD
Gemfibrozil—Dermatitis—Azathioprine—multiple sclerosis	0.000459	0.00144	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—multiple sclerosis	0.000459	0.00144	CcSEcCtD
Gemfibrozil—Headache—Azathioprine—multiple sclerosis	0.000457	0.00143	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—multiple sclerosis	0.000453	0.00142	CcSEcCtD
Gemfibrozil—Angioedema—Betamethasone—multiple sclerosis	0.000452	0.00142	CcSEcCtD
Gemfibrozil—Angioedema—Dexamethasone—multiple sclerosis	0.000452	0.00142	CcSEcCtD
Gemfibrozil—Confusional state—Methylprednisolone—multiple sclerosis	0.000448	0.0014	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000445	0.00139	CcSEcCtD
Gemfibrozil—Oedema—Triamcinolone—multiple sclerosis	0.000445	0.00139	CcSEcCtD
Gemfibrozil—Vertigo—Dexamethasone—multiple sclerosis	0.000444	0.00139	CcSEcCtD
Gemfibrozil—Vertigo—Betamethasone—multiple sclerosis	0.000444	0.00139	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000444	0.00139	CcSEcCtD
Gemfibrozil—Syncope—Dexamethasone—multiple sclerosis	0.000444	0.00139	CcSEcCtD
Gemfibrozil—Syncope—Betamethasone—multiple sclerosis	0.000444	0.00139	CcSEcCtD
Gemfibrozil—Shock—Triamcinolone—multiple sclerosis	0.000438	0.00137	CcSEcCtD
Gemfibrozil—Alopecia—Prednisone—multiple sclerosis	0.000437	0.00137	CcSEcCtD
Gemfibrozil—Shock—Methylprednisolone—multiple sclerosis	0.000437	0.00137	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000436	0.00635	CbGpPWpGaD
Gemfibrozil—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000436	0.00137	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000435	0.00136	CcSEcCtD
Gemfibrozil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000435	0.00136	CcSEcCtD
Gemfibrozil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000435	0.00136	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisolone—multiple sclerosis	0.000434	0.00136	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—multiple sclerosis	0.000433	0.00136	CcSEcCtD
Gemfibrozil—Nausea—Azathioprine—multiple sclerosis	0.000433	0.00136	CcSEcCtD
Gemfibrozil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000431	0.00135	CcSEcCtD
Gemfibrozil—Convulsion—Betamethasone—multiple sclerosis	0.000429	0.00134	CcSEcCtD
Gemfibrozil—Convulsion—Dexamethasone—multiple sclerosis	0.000429	0.00134	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000423	0.00617	CbGpPWpGaD
Gemfibrozil—Asthenia—Mitoxantrone—multiple sclerosis	0.000423	0.00133	CcSEcCtD
Gemfibrozil—Myalgia—Dexamethasone—multiple sclerosis	0.000421	0.00132	CcSEcCtD
Gemfibrozil—Myalgia—Betamethasone—multiple sclerosis	0.000421	0.00132	CcSEcCtD
Gemfibrozil—Pain—Prednisolone—multiple sclerosis	0.000414	0.0013	CcSEcCtD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000412	0.006	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000412	0.006	CbGpPWpGaD
Gemfibrozil—Vision blurred—Prednisone—multiple sclerosis	0.000406	0.00127	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000405	0.00127	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000404	0.00127	CcSEcCtD
Gemfibrozil—Oedema—Betamethasone—multiple sclerosis	0.000404	0.00127	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000404	0.00127	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000404	0.00127	CcSEcCtD
Gemfibrozil—Oedema—Dexamethasone—multiple sclerosis	0.000404	0.00127	CcSEcCtD
Gemfibrozil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000403	0.00127	CcSEcCtD
Gemfibrozil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000399	0.00125	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000399	0.00125	CcSEcCtD
Gemfibrozil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000399	0.00125	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—multiple sclerosis	0.000398	0.00125	CcSEcCtD
Gemfibrozil—Shock—Dexamethasone—multiple sclerosis	0.000397	0.00125	CcSEcCtD
Gemfibrozil—Shock—Betamethasone—multiple sclerosis	0.000397	0.00125	CcSEcCtD
Gemfibrozil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000396	0.00124	CcSEcCtD
Gemfibrozil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000396	0.00124	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000395	0.00124	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000395	0.00124	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—multiple sclerosis	0.000394	0.00123	CcSEcCtD
Gemfibrozil—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000392	0.00572	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000392	0.00571	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000392	0.00571	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000392	0.00123	CcSEcCtD
Gemfibrozil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000391	0.00123	CcSEcCtD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000387	0.00564	CbGpPWpGaD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000387	0.00564	CbGpPWpGaD
Gemfibrozil—Vertigo—Prednisone—multiple sclerosis	0.000387	0.00121	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—multiple sclerosis	0.000386	0.00121	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—multiple sclerosis	0.000386	0.00121	CcSEcCtD
Gemfibrozil—Urticaria—Prednisolone—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Gemfibrozil—Fatigue—Triamcinolone—multiple sclerosis	0.000384	0.0012	CcSEcCtD
Gemfibrozil—Fatigue—Methylprednisolone—multiple sclerosis	0.000383	0.0012	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000381	0.00555	CbGpPWpGaD
Gemfibrozil—Pain—Triamcinolone—multiple sclerosis	0.00038	0.00119	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—multiple sclerosis	0.000379	0.00119	CcSEcCtD
Gemfibrozil—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000376	0.00548	CbGpPWpGaD
Gemfibrozil—Vomiting—Mitoxantrone—multiple sclerosis	0.000375	0.00118	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—multiple sclerosis	0.000373	0.00117	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000373	0.00117	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000373	0.00543	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000373	0.00543	CbGpPWpGaD
Gemfibrozil—Rash—Mitoxantrone—multiple sclerosis	0.000372	0.00117	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000371	0.00116	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—multiple sclerosis	0.000369	0.00116	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000368	0.00115	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000368	0.00115	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—multiple sclerosis	0.000367	0.00115	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—multiple sclerosis	0.000367	0.00115	CcSEcCtD
Gemfibrozil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000367	0.00115	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000366	0.00115	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—multiple sclerosis	0.000365	0.00115	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000364	0.00114	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000363	0.00114	CcSEcCtD
Gemfibrozil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000362	0.00114	CcSEcCtD
Gemfibrozil—Paraesthesia—Betamethasone—multiple sclerosis	0.000362	0.00114	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—multiple sclerosis	0.000362	0.00114	CcSEcCtD
Gemfibrozil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000355	0.00111	CcSEcCtD
Gemfibrozil—Dyspepsia—Betamethasone—multiple sclerosis	0.000355	0.00111	CcSEcCtD
Gemfibrozil—Urticaria—Triamcinolone—multiple sclerosis	0.000353	0.00111	CcSEcCtD
Gemfibrozil—Urticaria—Methylprednisolone—multiple sclerosis	0.000353	0.00111	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—multiple sclerosis	0.000352	0.00111	CcSEcCtD
Gemfibrozil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000352	0.00513	CbGpPWpGaD
Gemfibrozil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000352	0.0011	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—multiple sclerosis	0.000352	0.0011	CcSEcCtD
Gemfibrozil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000351	0.0011	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—multiple sclerosis	0.00035	0.0011	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000348	0.00109	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000348	0.00109	CcSEcCtD
Gemfibrozil—Fatigue—Dexamethasone—multiple sclerosis	0.000348	0.00109	CcSEcCtD
Gemfibrozil—Fatigue—Betamethasone—multiple sclerosis	0.000348	0.00109	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—FAS—multiple sclerosis	0.000346	0.00505	CbGpPWpGaD
Gemfibrozil—Shock—Prednisone—multiple sclerosis	0.000346	0.00108	CcSEcCtD
Gemfibrozil—Pain—Betamethasone—multiple sclerosis	0.000345	0.00108	CcSEcCtD
Gemfibrozil—Pain—Dexamethasone—multiple sclerosis	0.000345	0.00108	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—multiple sclerosis	0.000345	0.00108	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—multiple sclerosis	0.000341	0.00107	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—multiple sclerosis	0.000339	0.00106	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—multiple sclerosis	0.000333	0.00104	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000333	0.00104	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000333	0.00104	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—ZNF746—multiple sclerosis	0.000331	0.00483	CbGpPWpGaD
Gemfibrozil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00033	0.00104	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00033	0.00104	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—multiple sclerosis	0.000323	0.00101	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—multiple sclerosis	0.000322	0.00101	CcSEcCtD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000321	0.00467	CbGpPWpGaD
Gemfibrozil—Urticaria—Betamethasone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Gemfibrozil—Urticaria—Dexamethasone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00032	0.001	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—multiple sclerosis	0.00032	0.001	CcSEcCtD
Gemfibrozil—Asthenia—Triamcinolone—multiple sclerosis	0.000319	0.001	CcSEcCtD
Gemfibrozil—Abdominal pain—Betamethasone—multiple sclerosis	0.000319	0.001	CcSEcCtD
Gemfibrozil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000319	0.001	CcSEcCtD
Gemfibrozil—Asthenia—Methylprednisolone—multiple sclerosis	0.000318	0.000999	CcSEcCtD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000318	0.00463	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000318	0.00463	CbGpPWpGaD
Gemfibrozil—Paraesthesia—Prednisone—multiple sclerosis	0.000316	0.00099	CcSEcCtD
Gemfibrozil—Pruritus—Triamcinolone—multiple sclerosis	0.000315	0.000987	CcSEcCtD
Gemfibrozil—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000315	0.00458	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000315	0.00458	CbGpPWpGaD
Gemfibrozil—Cough—Methotrexate—multiple sclerosis	0.000314	0.000985	CcSEcCtD
Gemfibrozil—Pruritus—Methylprednisolone—multiple sclerosis	0.000314	0.000985	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—multiple sclerosis	0.000312	0.000978	CcSEcCtD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00031	0.00452	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00031	0.00452	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Prednisone—multiple sclerosis	0.000309	0.00097	CcSEcCtD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000306	0.00447	CbGpPWpGaD
Gemfibrozil—Chest pain—Methotrexate—multiple sclerosis	0.000306	0.000961	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—multiple sclerosis	0.000306	0.000961	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—multiple sclerosis	0.000306	0.000961	CcSEcCtD
Gemfibrozil—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000306	0.00445	CbGpPWpGaD
Gemfibrozil—Rash—Prednisolone—multiple sclerosis	0.000305	0.000956	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—multiple sclerosis	0.000305	0.000956	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000304	0.000954	CcSEcCtD
Gemfibrozil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000304	0.000952	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—multiple sclerosis	0.000303	0.00095	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—multiple sclerosis	0.000303	0.00095	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—PTBP1—multiple sclerosis	0.000303	0.00441	CbGpPWpGaD
Gemfibrozil—Constipation—Prednisone—multiple sclerosis	0.000301	0.000943	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—multiple sclerosis	0.000296	0.000929	CcSEcCtD
Gemfibrozil—Dizziness—Triamcinolone—multiple sclerosis	0.000294	0.000922	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000294	0.000921	CcSEcCtD
Gemfibrozil—Dizziness—Methylprednisolone—multiple sclerosis	0.000294	0.00092	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—multiple sclerosis	0.00029	0.000908	CcSEcCtD
Gemfibrozil—Asthenia—Dexamethasone—multiple sclerosis	0.00029	0.000908	CcSEcCtD
Gemfibrozil—Asthenia—Betamethasone—multiple sclerosis	0.00029	0.000908	CcSEcCtD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000289	0.00421	CbGpPWpGaD
Gemfibrozil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000288	0.000903	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000288	0.000902	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000287	0.000901	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—multiple sclerosis	0.000287	0.000901	CcSEcCtD
Gemfibrozil—Pruritus—Betamethasone—multiple sclerosis	0.000286	0.000895	CcSEcCtD
Gemfibrozil—Pruritus—Dexamethasone—multiple sclerosis	0.000286	0.000895	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—multiple sclerosis	0.000285	0.000895	CcSEcCtD
Gemfibrozil—Vomiting—Triamcinolone—multiple sclerosis	0.000283	0.000887	CcSEcCtD
Gemfibrozil—Vomiting—Methylprednisolone—multiple sclerosis	0.000282	0.000885	CcSEcCtD
Gemfibrozil—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000281	0.00409	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000281	0.00409	CbGpPWpGaD
Gemfibrozil—Rash—Triamcinolone—multiple sclerosis	0.00028	0.00088	CcSEcCtD
Gemfibrozil—Dermatitis—Triamcinolone—multiple sclerosis	0.00028	0.000879	CcSEcCtD
Gemfibrozil—Rash—Methylprednisolone—multiple sclerosis	0.00028	0.000878	CcSEcCtD
Gemfibrozil—Dermatitis—Methylprednisolone—multiple sclerosis	0.00028	0.000877	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—multiple sclerosis	0.000279	0.000876	CcSEcCtD
Gemfibrozil—Headache—Triamcinolone—multiple sclerosis	0.000279	0.000874	CcSEcCtD
Gemfibrozil—Headache—Methylprednisolone—multiple sclerosis	0.000278	0.000872	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—multiple sclerosis	0.000278	0.000871	CcSEcCtD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000277	0.00404	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000277	0.00404	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Betamethasone—multiple sclerosis	0.000276	0.000866	CcSEcCtD
Gemfibrozil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000276	0.000866	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000274	0.00399	CbGpPWpGaD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000268	0.000839	CcSEcCtD
Gemfibrozil—Dizziness—Dexamethasone—multiple sclerosis	0.000267	0.000837	CcSEcCtD
Gemfibrozil—Dizziness—Betamethasone—multiple sclerosis	0.000267	0.000837	CcSEcCtD
Gemfibrozil—Nausea—Triamcinolone—multiple sclerosis	0.000264	0.000829	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—multiple sclerosis	0.000264	0.000827	CcSEcCtD
Gemfibrozil—Nausea—Methylprednisolone—multiple sclerosis	0.000264	0.000827	CcSEcCtD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000262	0.00382	CbGpPWpGaD
Gemfibrozil—Somnolence—Methotrexate—multiple sclerosis	0.000261	0.000819	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—multiple sclerosis	0.000259	0.000811	CcSEcCtD
Gemfibrozil—Vomiting—Betamethasone—multiple sclerosis	0.000257	0.000805	CcSEcCtD
Gemfibrozil—Vomiting—Dexamethasone—multiple sclerosis	0.000257	0.000805	CcSEcCtD
Gemfibrozil—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000256	0.00373	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000256	0.00373	CbGpPWpGaD
Gemfibrozil—Rash—Dexamethasone—multiple sclerosis	0.000255	0.000798	CcSEcCtD
Gemfibrozil—Rash—Betamethasone—multiple sclerosis	0.000255	0.000798	CcSEcCtD
Gemfibrozil—Dermatitis—Dexamethasone—multiple sclerosis	0.000254	0.000797	CcSEcCtD
Gemfibrozil—Dermatitis—Betamethasone—multiple sclerosis	0.000254	0.000797	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000254	0.000795	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—multiple sclerosis	0.000253	0.000794	CcSEcCtD
Gemfibrozil—Headache—Dexamethasone—multiple sclerosis	0.000253	0.000793	CcSEcCtD
Gemfibrozil—Headache—Betamethasone—multiple sclerosis	0.000253	0.000793	CcSEcCtD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000253	0.00368	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000253	0.00368	CbGpPWpGaD
Gemfibrozil—Asthenia—Prednisone—multiple sclerosis	0.000252	0.000791	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—multiple sclerosis	0.000251	0.000788	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—multiple sclerosis	0.000249	0.00078	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—FAS—multiple sclerosis	0.000244	0.00356	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000242	0.000759	CcSEcCtD
Gemfibrozil—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000242	0.00352	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Prednisone—multiple sclerosis	0.000241	0.000754	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00024	0.000753	CcSEcCtD
Gemfibrozil—Nausea—Betamethasone—multiple sclerosis	0.00024	0.000752	CcSEcCtD
Gemfibrozil—Nausea—Dexamethasone—multiple sclerosis	0.00024	0.000752	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—PRNP—multiple sclerosis	0.00024	0.00349	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000239	0.00349	CbGpPWpGaD
Gemfibrozil—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000238	0.00347	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SRM—multiple sclerosis	0.000236	0.00343	CbGpPWpGaD
Gemfibrozil—Urticaria—Methotrexate—multiple sclerosis	0.000233	0.000732	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—multiple sclerosis	0.000232	0.000729	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—multiple sclerosis	0.000232	0.000728	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—U2AF2—multiple sclerosis	0.00023	0.00334	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—HNRNPA1—multiple sclerosis	0.00023	0.00334	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000228	0.00333	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000224	0.00327	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000224	0.00326	CbGpPWpGaD
Gemfibrozil—Vomiting—Prednisone—multiple sclerosis	0.000224	0.000701	CcSEcCtD
Gemfibrozil—Rash—Prednisone—multiple sclerosis	0.000222	0.000695	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—multiple sclerosis	0.000221	0.000694	CcSEcCtD
Gemfibrozil—Headache—Prednisone—multiple sclerosis	0.00022	0.000691	CcSEcCtD
Gemfibrozil—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000219	0.00319	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000219	0.00319	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000216	0.00314	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000216	0.00314	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000215	0.00313	CbGpPWpGaD
Gemfibrozil—Asthenia—Methotrexate—multiple sclerosis	0.000211	0.000661	CcSEcCtD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00021	0.00306	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00021	0.00306	CbGpPWpGaD
Gemfibrozil—Nausea—Prednisone—multiple sclerosis	0.000209	0.000655	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—multiple sclerosis	0.000208	0.000652	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000208	0.00302	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000202	0.00295	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000202	0.00294	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Methotrexate—multiple sclerosis	0.000201	0.00063	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—multiple sclerosis	0.000194	0.000609	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—multiple sclerosis	0.000187	0.000586	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—PTPRC—multiple sclerosis	0.000186	0.00272	CbGpPWpGaD
Gemfibrozil—Rash—Methotrexate—multiple sclerosis	0.000185	0.000581	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—multiple sclerosis	0.000185	0.00058	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—multiple sclerosis	0.000184	0.000577	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—ZFP36L1—multiple sclerosis	0.000181	0.00264	CbGpPWpGaD
Gemfibrozil—Nausea—Methotrexate—multiple sclerosis	0.000174	0.000547	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—STAT3—multiple sclerosis	0.00017	0.00248	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000169	0.00246	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000169	0.00246	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000167	0.00243	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000167	0.00243	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP24A1—multiple sclerosis	0.000166	0.00242	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP27B1—multiple sclerosis	0.000166	0.00242	CbGpPWpGaD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000164	0.00239	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000163	0.00237	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000162	0.00236	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TGFB1—multiple sclerosis	0.000157	0.00229	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GPC5—multiple sclerosis	0.000152	0.00221	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TNF—multiple sclerosis	0.000147	0.00214	CbGpPWpGaD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000147	0.00214	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000145	0.00211	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PABPC1—multiple sclerosis	0.000141	0.00205	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000134	0.00195	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000133	0.00194	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SRM—multiple sclerosis	0.000133	0.00194	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000129	0.00188	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—RPL5—multiple sclerosis	0.000127	0.00185	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RRM1—multiple sclerosis	0.000126	0.00183	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000121	0.00176	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000121	0.00176	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000119	0.00173	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IL6—multiple sclerosis	0.000119	0.00173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000118	0.00171	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000114	0.00167	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000114	0.00166	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.00158	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000108	0.00157	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000108	0.00157	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000105	0.00153	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000105	0.00152	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PGR—multiple sclerosis	9.99e-05	0.00146	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.83e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.83e-05	0.00143	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.76e-05	0.00142	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	9.37e-05	0.00136	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	9.37e-05	0.00136	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.27e-05	0.00135	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.15e-05	0.00133	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.82e-05	0.00129	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GPC5—multiple sclerosis	8.57e-05	0.00125	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.4e-05	0.00122	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.4e-05	0.00122	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.38e-05	0.00122	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—IL6—multiple sclerosis	8.37e-05	0.00122	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TYK2—multiple sclerosis	8.34e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	8.17e-05	0.00119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	8.15e-05	0.00119	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.07e-05	0.00118	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	8e-05	0.00117	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.64e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SRM—multiple sclerosis	7.64e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	7.61e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.61e-05	0.00111	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.27e-05	0.00106	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—BCHE—multiple sclerosis	7.22e-05	0.00105	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.15e-05	0.00104	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RRM1—multiple sclerosis	7.1e-05	0.00103	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—POMC—multiple sclerosis	7.08e-05	0.00103	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—VDR—multiple sclerosis	6.98e-05	0.00102	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SRM—multiple sclerosis	6.82e-05	0.000993	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—multiple sclerosis	6.57e-05	0.000957	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.32e-05	0.000921	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SRM—multiple sclerosis	6.22e-05	0.000906	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—STAT3—multiple sclerosis	5.84e-05	0.000851	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—multiple sclerosis	5.76e-05	0.00084	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	5.76e-05	0.000839	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.51e-05	0.000802	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TGFB1—multiple sclerosis	5.41e-05	0.000789	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	5.38e-05	0.000784	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	5.38e-05	0.000784	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SRM—multiple sclerosis	5.31e-05	0.000774	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MAPK1—multiple sclerosis	5.31e-05	0.000773	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.26e-05	0.000766	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—multiple sclerosis	5.05e-05	0.000736	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.92e-05	0.000717	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPC5—multiple sclerosis	4.92e-05	0.000717	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.8e-05	0.0007	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.8e-05	0.0007	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.73e-05	0.000689	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.69e-05	0.000684	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.39e-05	0.00064	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4.38e-05	0.000638	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4.38e-05	0.000638	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—APOE—multiple sclerosis	4.35e-05	0.000633	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.31e-05	0.000628	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.28e-05	0.000624	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.1e-05	0.000597	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SRM—multiple sclerosis	4.1e-05	0.000597	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—multiple sclerosis	4.08e-05	0.000594	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RRM1—multiple sclerosis	4.08e-05	0.000594	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—BCHE—multiple sclerosis	4.08e-05	0.000594	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.01e-05	0.000584	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.8e-05	0.000554	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.74e-05	0.000545	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.74e-05	0.000545	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—POMC—multiple sclerosis	3.73e-05	0.000544	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.66e-05	0.000533	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.64e-05	0.00053	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.42e-05	0.000499	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALB—multiple sclerosis	3.4e-05	0.000496	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.32e-05	0.000484	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.16e-05	0.000461	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.89e-05	0.000421	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.89e-05	0.000421	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.84e-05	0.000413	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.82e-05	0.000411	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—multiple sclerosis	2.78e-05	0.000404	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.72e-05	0.000396	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.64e-05	0.000385	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.58e-05	0.000375	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.48e-05	0.000361	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—APOE—multiple sclerosis	2.45e-05	0.000357	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.43e-05	0.000353	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.34e-05	0.000341	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.21e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.21e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.2e-05	0.000321	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000319	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—POMC—multiple sclerosis	2.11e-05	0.000307	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.09e-05	0.000305	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.02e-05	0.000294	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.92e-05	0.00028	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.91e-05	0.000278	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.89e-05	0.000275	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.72e-05	0.000251	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000237	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOE—multiple sclerosis	1.41e-05	0.000205	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOE—multiple sclerosis	1.26e-05	0.000183	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000183	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000176	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—POMC—multiple sclerosis	9.85e-06	0.000144	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—multiple sclerosis	9.85e-06	0.000144	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOE—multiple sclerosis	9.8e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—multiple sclerosis	8.98e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—POMC—multiple sclerosis	8.42e-06	0.000123	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—multiple sclerosis	7.68e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOE—multiple sclerosis	7.56e-06	0.00011	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—POMC—multiple sclerosis	6.5e-06	9.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—multiple sclerosis	5.92e-06	8.63e-05	CbGpPWpGaD
